Magnetic resonance imaging contrast agents: Overview and perspectives

被引:156
作者
Yan, Guo-Ping [1 ,2 ]
Robinson, Leslie [3 ]
Hogg, Peter [3 ]
机构
[1] Wuhan Inst Technol, Sch Mat Sci & Engn, 693 Xiongchu Rd, Wuhan 430073, Hubei Province, Peoples R China
[2] Queensland Univ Technol, Sch Phys & Chem Sci, Brisbane, Qld 4001, Australia
[3] Univ Salford, Sch Hlth Care Profess, Manchester M6 6PU, Lancs, England
基金
澳大利亚研究理事会;
关键词
Magnetic resonance imaging (MRI); Contrast agents; Paramagnetic; Superparamagnetic; Gadolinium(III); Tissue or organ-targeting;
D O I
10.1016/j.radi.2006.07.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Magnetic resonance imaging (MRI) is a non-invasive clinical imaging modality, which has become widely used in the diagnosis and/or staging of human diseases around the world. Some MRI examinations include the use of contrast agents. The categorizations of currently available contrast agents have been described according to their effect on the image, magnetic behavior and biodistribution in the body, respectively. In this field, superparamagnetic iron oxide particles and soluble paramagnetic metal chelates are two main classes of contrast agents for MRI. This review outlines the research and development of MRI contrast agents. In future, the ideal MRI contrast agent will be focused on the neutral tissue-or organ-targeting materials with high relaxivity and specificity, low toxicity and side effects, suitable long intravascular duration and excretion time, high contrast enhancement with low dose in vivo, and with minimal cost. (C) 2006 The College of Radiographers. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:E5 / E19
页数:15
相关论文
共 171 条
  • [1] Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model
    Adzamli, K
    Yablonskiy, DA
    Chicoine, MR
    Won, EK
    Galen, KP
    Zahner, MC
    Woolsey, TA
    Ackerman, JJH
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) : 586 - 590
  • [2] Towards MRI contrast agents of improved efficacy. NMR relaxometric investigations of the binding interaction to HSA of a novel heptadentate macrocyclic triphosphonate Gd(III)-complex
    Aime, S
    Botta, M
    Crich, SG
    Giovenzana, GB
    Pagliarin, R
    Piccinini, M
    Sisti, M
    Terreno, E
    [J]. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 1997, 2 (04): : 470 - 479
  • [3] Innovative magnetic resonance imaging diagnostic agents based on paramagnetic Gd(III) complexes
    Aime, S
    Dastrù, W
    Crich, SG
    Gianolio, E
    Mainero, V
    [J]. BIOPOLYMERS, 2002, 66 (06) : 419 - 428
  • [4] β-cyclodextrin adducts of Gd(III) chelates:: useful models for investigating the structural and dynamic determinants of the relaxivity of gadolinium-based systems
    Aime, S
    Gianolio, E
    Terreno, E
    Menegotto, I
    Bracco, C
    Milone, L
    Cravotto, G
    [J]. MAGNETIC RESONANCE IN CHEMISTRY, 2003, 41 (10) : 800 - 805
  • [5] Aime S, 2001, CHEM-EUR J, V7, P5262, DOI 10.1002/1521-3765(20011217)7:24<5261::AID-CHEM5261>3.0.CO
  • [6] 2-D
  • [7] Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO
  • [8] 2-P
  • [9] GD(DOTP)5-OUTER-SPHERE RELAXATION ENHANCEMENT PROMOTED BY NITROGEN BASES
    AIME, S
    BOTTA, M
    TERRENO, E
    ANELLI, PL
    UGGERI, F
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1993, 30 (05) : 583 - 591
  • [10] Aime S., 2000, ANGEW CHEM, V112, P763